The plaintiffs already have part of their case established. It's like Merck has conceded the first four rounds of a 15-round fight.

148

They may try to argue that while there was some risk at 18 months, it was minimal and the real problem came at three years. That would push the bar back further just in time to defend themselves from claims by long-term users.

70